VP-16

etoposide

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VP-16, covering 2020-10-22 to 2022-06-16. Get the full timeline:

Most recent: Clinical Trial Update: Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer [Phase 2]